序号 |
标题 |
次数 |
作者 |
发布时间 |
86176 |
十二酰基-β-环糊精聚砜共混膜 |
125 |
h |
2024-11-28 |
86177 |
DOTA-TRIS(TBE)-AMIDO-DPEG 4-TFP ESTER |
101 |
zyl |
2024-11-28 |
86178 |
[DOTA0,Tyr 3]-奥曲肽, [DOTA0,Tyr 3]-octreotate |
132 |
kx |
2024-11-28 |
86179 |
β-环糊精/聚多巴胺功能化聚氨酯/聚偏氟乙烯纤维膜 PU/PVDF/s-PDA/cm-β-CD |
127 |
h |
2024-11-28 |
86180 |
十三肽DOTA-LGEYGFQNALIVR;1262403-92-8 |
131 |
zcy |
2024-11-28 |
86181 |
DOTA-functionalized silica gel |
132 |
zyl |
2024-11-28 |
86182 |
静电纺β-环糊精/石墨烯载银抗菌纤维膜 |
92 |
h |
2024-11-28 |
86183 |
1-[6-(3,5-二甲基-1H-吡唑-1-基)-1,2,4,5-四嗪-3-基]酰肼 |
94 |
WYQ |
2024-11-28 |
86184 |
3-胍基-6(3,5-二甲基吡唑)-1,2,4,5-四嗪高氯酸盐甲醇合物(BGTz·HClO4·CH3OH) |
113 |
WYQ |
2024-11-28 |
86185 |
DOTA-Maleimide马来酰亚胺-DOTA大环螯合剂 |
116 |
zcy |
2024-11-28 |
86186 |
SSSS-SSSS-M4DOTMA , 带有四个SSSS甲基的刚性化和对称的多甲基化的四氮杂环DOTA |
163 |
kx |
2024-11-28 |
86187 |
DOTA-tris(t-Bu)-Amido-PEG7-Amine |
110 |
zyl |
2024-11-28 |
86188 |
3-取代-4-氧-3H-咪唑并[5,1-d][1,2,3,5]四嗪-8-羧酸衍生物 |
131 |
WYQ |
2024-11-28 |
86189 |
p-SCN-Bn-DOTA,127985-74-4,双功能螯合剂 |
205 |
zcy |
2024-11-28 |
86190 |
DOTA-tris(t-Bu)-Amido-PEG11-Bromoacetamide |
138 |
zyl |
2024-11-28 |
86191 |
DOTA-PEG-硫辛酸, DOTA-PEG-LA |
148 |
kx |
2024-11-28 |
86192 |
DOTA-tris(t-Bu)-Amido-PEG24-NHS Ester |
120 |
zyl |
2024-11-28 |
86193 |
N-邻甲基苯-3-苯基-6-甲基-1,6-二氢-1,2,4,5-四嗪-1-甲酰胺 |
152 |
WYQ |
2024-11-28 |
86194 |
Biotin peptide,多肽生物素修饰 |
231 |
zcy |
2024-11-28 |
86195 |
3-芳基-6-甲基-1,6-二氢-1,2,4,5-四嗪 |
193 |
WYQ |
2024-11-28 |
86196 |
双功能螯合剂DOTA共轭RAWVAWR-NH2,DOTA-RAWVAWR-NH2 |
122 |
kx |
2024-11-28 |
86197 |
Lu-DOTA-TATE/Ga-DOTA-TRP 大环化合物 |
195 |
zcy |
2024-11-28 |
86198 |
偕胺肟化聚丙烯腈-β-环糊精纳米纤维膜 AOPAN-β-CD |
297 |
h |
2024-11-28 |
86199 |
cFLFLFK-MHI-DOTA, 靶向多模式探针 |
166 |
kx |
2024-11-28 |
86200 |
β-环糊精改性纤维膜 |
117 |
h |
2024-11-28 |
86201 |
EuropiuM DOTA SodiuM Salt Hydrate |
122 |
zyl |
2024-11-28 |
86202 |
CAS:753421-63-5 4-Aminobutyl-DOTA |
99 |
zyl |
2024-11-28 |
86203 |
Pteroyl-Lys-DOTA ,蝶酰-Lys-DOTA DOTA缀合的蝶酰-Lys衍生物 |
143 |
kx |
2024-11-28 |
86204 |
丙烯酸乙酯与丙烯酰胺接枝淀粉/β-环糊精树脂 EA-AM/β-CD |
131 |
h |
2024-11-28 |
86205 |
VIP-DOTA(靶向VPAC2-R) |
189 |
kx |
2024-11-28 |
86206 |
大环造影剂CAS:2126179-28-8;Ho-p-SCN-Bn-DOTA |
118 |
zyl |
2024-11-28 |
86207 |
Na[Gd(DOTA)·H2O]大环配合物 |
139 |
kx |
2024-11-28 |
86208 |
44Sc-DOTA-ZHER2:2891 , 亲和体分子ZHER2:2891偶联DOTA螯合剂 |
258 |
kx |
2024-11-28 |
86209 |
3,6-二胍基-1,2,4,5-四嗪高氯酸盐[DGTz·2(HClO4)] |
150 |
WYQ |
2024-11-28 |
86210 |
DOTA-三(酸) - 酰胺-DPEG(R)24-酰氨基-DPEG(R)24-DSPE |
108 |
zyl |
2024-11-28 |
86211 |
β-环糊精改性聚(氯甲基苯乙烯)树脂 β-CD/PS-Cl |
107 |
h |
2024-11-28 |
86212 |
3,6-二肼基-1,2,4,5-四嗪3,5-二硝基水杨酸盐二水合物(DHTz·DNSA-2H2O) |
171 |
WYQ |
2024-11-28 |
86213 |
DOTA-TOC,204318-14-9,依多曲肽 |
128 |
zcy |
2024-11-28 |
86214 |
DOTA-TRIS(TBE) - 酰胺基DPEG(R)11-马来酰亚胺 |
126 |
zyl |
2024-11-28 |
86215 |
β-环糊精改性机蒙脱七跟环氧树脂 E-44-β-CD |
215 |
h |
2024-11-28 |
86216 |
86Y-DOTA-Bn , 钇-86-DOTA-铃蟾肽 |
204 |
kx |
2024-11-28 |
86217 |
Gd-NOTA;钆-大环配体NOTA |
116 |
zcy |
2024-11-28 |
86218 |
3,6-二肼基-1,2,4,5-四嗪(DHTz) |
199 |
WYQ |
2024-11-28 |
86219 |
环糊精改性的脲醛树脂 CD-UF |
130 |
h |
2024-11-28 |
86220 |
CAS:177943-89-4 DOTATATE acetate |
180 |
zyl |
2024-11-28 |